IDH2 and acute myeloid leukemia: We found that IDH2 expression was significantly higher in AML cells compared to the normal samples (Fig. 1a, b), and patients with higher IDH2 expression exhibited a tendency of poor clinical outcome (Additional file 3: Fig. S1a).